Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04557189 · ClinicalTrials.gov registry record · Phase 2
A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery
A Phase 2 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 2
- Development phase
- 89
- Enrollment target
NCT04557189 is a Phase 2 study that has completed, run by Takeda. The registered enrollment target is 89 participants.
The verdict
NCT04557189, a Phase 2 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 89 participants
- Enrollment target
Study Summary
Some adults are at a higher risk of feeling sick (nausea) or being sick (vomiting) after they have surgery. In this study, these adults will have planned surgery. The main aim of this study is to learn if TAK-951 stops these adults from getting nausea or vomiting after surgery. This will be compared with another medicine called ondansetron. Another aim is to check for side effects from the study medicines. Before surgery, the study doctor will check who can take part in this study. Those who can take part will be picked for either Treatment Group A or Treatment Group B by chance. * Treatment Group A: Just before surgery, participants will receive a placebo slowly through a vein (infusion). Just before the end of the surgery, they will receive TAK-951 as an injection under the skin. * Treatment Group B: Just before surgery, participants will receive ondansetron slowly through a vein (infusion). Just before the end of the surgery, they will receive a placebo as an injection under the skin. In this study, a placebo will look like TAK-951 but will not have any medicine in it. Participants will not know which study medicines they received, or in which order, nor will their study doctors or surgeons. This is to help make sure the results are more reliable. Participants will stay in the hospital for 24 hours after their surgery so that the study doctors can check for nausea and vomiting. The study doctors will also check for side effects from the study medicines. Participants will visit the hospital for a check-up 14 days later.
Interventions
- DRUG Ondansetron
- DRUG TAK-951
- DRUG Ondansetron Placebo
- DRUG TAK-951 Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2020-10-20 |
| Est. Completion | 2022-03-21 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04557189
The ClinicalTrials.gov registry entry for NCT04557189 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ondansetron is the first listed.
NCT04557189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04557189 about?
NCT04557189 is a clinical study titled "A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery". Some adults are at a higher risk of feeling sick (nausea) or being sick (vomiting) after they have surgery. In this study, these adults will have planned surgery. The main aim of this study is to learn if TAK-951 stops these adults from getting nausea or vomiting after surgery. This will be compared...
What is the current status of trial NCT04557189?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 89 participants. The study started on 2020-10-20. Estimated completion is 2022-03-21.
What interventions are being tested in trial NCT04557189?
The interventions under investigation include: Ondansetron (DRUG), TAK-951 (DRUG), Ondansetron Placebo (DRUG), TAK-951 Placebo (DRUG).
Who is sponsoring clinical trial NCT04557189?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.